Associations Among 25-Hydroxyvitamin D Levels, Lung Function, and Exacerbation Outcomes in COPD is a research paper published in CHEST Journal (2020). On theSindex it has a DataRank of 0.601. It has been cited 54 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.601
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Heart, Lung, and Blood Institute
Grant: R01HL125432-01A1
National Heart, Lung, and Blood Institute
Grant: HHSN268200900020C
National Heart, Lung, and Blood Institute
Grant: U01 HL137880
NIAID NIH HHS
Grant: R01 AI129958
NIH HHS
Grant: S10 OD018526
NHLBI NIH HHS
Grant: K24 HL137013
NHLBI NIH HHS
Grant: HHSN268200900015C
NHLBI NIH HHS
Grant: HHSN268200900018C
NIEHS NIH HHS
Grant: P30 ES005605
NHLBI NIH HHS
Grant: T32 HL007749
NHLBI NIH HHS
Grant: K08 HL123940
NHLBI NIH HHS
Grant: R01 HL125432
NHLBI NIH HHS
Grant: U24 HL141762
NHLBI NIH HHS
Grant: HHSN268200900017C
NIDDK NIH HHS
Grant: P30 DK054759
NHLBI NIH HHS
Grant: HHSN268200900013C
NHLBI NIH HHS
Grant: HHSN268200900014C
NHLBI NIH HHS
Grant: HHSN268200900016C
NHLBI NIH HHS
Grant: F32 HL143867
NHLBI NIH HHS
Grant: HHSN268200900019C
National Institutes of Health
Grant: 5F32HL143867-02
Clinical Significance of the Antimicrobial Peptide Cathelicidin in Acute Exacerbations of COPD
National Institutes of Health
Grant: 5U01HL137880-04
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progression
National Institutes of Health
Grant: 7R01HL125432-03
Cathelicidin and Vitamin D: Impact on Populations At-Risk and with COPD
AbbVie
National Institutes of Health
King Pharmaceuticals
Boehringer Ingelheim
Sanofi
Amgen
Bellerophon Therapeutics
Gilead UK and Ireland Corporate Contributions
GlaxoSmithKline
U.S. Department of Defense
AstraZeneca
Bayer Fund
Sunovion
Takeda Pharmaceutical Company
University of Iowa
COPD Foundation
Forest Research Institute
Merck
Regeneron Pharmaceuticals
National Center for Advancing Translational Sciences
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Serum antioxidant vitamins and respiratory morbidity and mortality: a pooled analysis
Additional file 1 of Serum antioxidant vitamins and respiratory morbidity and mortality: a pooled analysis